Briefing
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
NEJM 2004 quantification study showing that plasma EBV DNA is a prognostic marker in advanced nasopharyngeal carcinoma.
- Design: Evidence level 2
- Assay: Not named in the abstract